Major Study Shows Mpox During Early Pregnancy Linked to 51% Adverse Outcomes
Lancet study from DRC finds 51% of pregnant women with mpox experienced adverse outcomes including 45% fetal loss rate. First trimester infection carries highest risk.
Read More